DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Aurora SK, Dodick DW, Diener HC. et al.
Onabotulinumtoxin A for chronic migraine: efficacy, safety and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
Acta Neurol Scand 2014;
129: 61-70
doi:10.1111/ane.12171
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.